Lv11
40 积分 2022-09-14 加入
Novel thieno[2,3-b]pyridine derivatives protect islet through DRAK2 kinase inhibition
5小时前
待确认
Trends in the drug target landscape for autoimmune diseases
17天前
已完结
Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma
1个月前
已关闭
A Phase 2 Study of MORF-057, an Oral α4β7 Integrin Inhibitor in Moderately to Severely Active Ulcerative Colitis
1个月前
已完结
Discovery of a Potent, Selective, and Brain-Penetrant CheckpointKinase 1 inhibitor, BEN-28010, for the Treatment of Glioblastoma
3个月前
已完结
MK2: a novel molecular target for anti-inflammatory therapy
3个月前
已完结
Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2) as Treatment for Inflammatory Diseases
3个月前
已完结
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
3个月前
已完结
Successful Treatment of Patients With Refractory PLA2R-Associated Membranous Nephropathy With Obinutuzumab: A Report of 3 Cases
3个月前
已完结
DRAK2 regulates myosin light chain phosphorylation in T cells
4个月前
已完结
皖公网安备34019202002308
